Larvol Delta - Dr-Vince-Clinical-Research-Announces-First-Dosing-in-Cingulate-Therapeutics-CTx1301-Phase-III-Laboratory-Classroom-Study-in-ADHD-Patients

dexmethylphenidate tri-modal release (CTx-1301) - Cingulate Therap

https://www.businesswire.com/news/home/20230906222260/en/Dr.-Vince-Clinical-Research-Announces-First-Dosing-in-Cingulate-Therapeutics%E2%80%99-CTx-1301-Phase-III-Laboratory-Classroom-Study-in-ADHD-Patients

Sep 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next